USANA Health Sciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
USANA Health Sciences (USNA) Tops Q2 EPS by 24c, Revenues Beat; Raises FY20 EPS/Revenue Outlook
July 21, 2020 4:19 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.32, $0.24 better than the analyst estimate of $1.08. Revenue for the quarter came in at $259 million versus the consensus estimate of $256.33 million.
Key Financial & Operating Highlights
Continued strong demand and successful promotions combined to generate $259.0 million in net sales and $1.32 in diluted EPS during the quarterActive customers increased 7.9% vs. the prior-year quarterCompany continued to successfully execute a virtual sales and operating strategy to deliver resultsCompany raises full-year 2020 Net Sales and EPS outlookStrong consumer demand for our high-quality, health products and... More



